文献速递造血干细胞移植与细胞治疗血栓与止血

HIF-1α上调促进移植相关血栓性微血管病中的补体激活

Upregulation of HIF-1α contributes to complement activation in transplantation-associated thrombotic microangiopathy.
PubMed 文献 · Br J Haematol · 2022-07-21

本研究检测21例移植相关血栓性微血管病(TA-TMA)患者及1:1匹配对照的HIF-1α与补体蛋白,并在体外和体内探究机制。发现TA-TMA患者HIF-1α显著升高,HIF-1α上调可诱导内皮细胞膜结合C3增加及功能障碍,体内升高HIF-1α导致野生型而非C3-/-小鼠出现肾小球C3和C5b-9沉积、血小板减少、贫血及LDH升高。HIF-1α与补体因子H(CFH)启动子相互作用抑制其转录,CFH降低导致内皮细胞补体激活。

要点

  • TA-TMA患者HIF-1α水平显著高于非TA-TMA对照。
  • 体外HIF-1α上调增加内皮细胞膜结合C3并致功能障碍。
  • HIF-1α通过抑制CFH转录导致内皮细胞补体激活。

核心结论

  • HIF-1α上调通过抑制CFH转录导致补体激活,参与TA-TMA发病。

研究设计与样本

  • 检测21例TA-TMA样本及1:1匹配对照的HIF-1α和补体蛋白水平。
  • 体外和体内实验探究HIF-1α上调导致补体激活的机制。

主要发现

  • TA-TMA患者HIF-1α水平显著高于非TA-TMA对照。
  • 体外HIF-1α上调诱导人脐静脉内皮细胞膜结合C3增加及功能障碍。
  • 体内升高HIF-1α导致野生型而非C3-/-小鼠肾小球内皮毛细血管复合物C3和C5b-9沉积、血小板减少、贫血及血清LDH升高。
  • DMOG处理小鼠出现外周血血小板高聚集及肾脏CD41阳性微血栓,重现TA-TMA表型。
  • HIF-1α与CFH启动子相互作用抑制其转录,CFH降低导致内皮细胞补体激活。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transplantation-associated thrombotic microangiopathy (TA-TMA) is a severe complication of haematopoietic stem cell transplantation (HSCT). Complement activation is involved in the development of TA-TMA. However, the underlying mechanism is unclear. Therefore, 21 samples of TA-TMA and 1:1 matched controls were measured for hypoxia-inducible factor-1α (HIF-1α) and complement protein. The mechanism was investigated both in vitro and in vivo. In this study, we found that levels of HIF-1α were significantly higher in TA-TMA patients than that in non-TA-TMA controls. Upregulation of HIF-1α induced an increase in membrane-bound complement C3 and dysfunction of human umbilical vein endothelial cells (HUVECs) in vitro. Increasing HIF-1α in vivo led to C3 and C5b-9 deposition in the glomerular endothelial capillary complex, thrombocytopenia, anaemia, and increased serum lactate dehydrogenase (LDH) levels in wild-type (WT) but not in C3-/- mice subjected to HSCT. High platelet aggregation in peripheral blood and CD41-positive microthrombi in the kidney were also found in dimethyloxallyl glycine (DMOG)-treated mice, recapitulating the TA-TMA phenotype seen in patients. Comprehensive analysis, including DNA array, luciferase reporter assay, chromatin immunoprecipitation (ChIP)-seq, and quantitative polymerase chain reaction (PCR), revealed that HIF-1α interacted with the promoter of complement factor H (CFH) to inhibit its transcription. Decreased CFH led to complement activation in endothelial cells.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Qi J, Pan T, You T, et al. Upregulation of HIF-1α contributes to complement activation in transplantation-associated thrombotic microangiopathy. Br J Haematol. 2022. PMID: 35864790. doi:10.1111/bjh.18377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。